CA1008074A - Derives arylamino pyrimidiniques, leur procede de preparation et leur application en therapeutique - Google Patents

Derives arylamino pyrimidiniques, leur procede de preparation et leur application en therapeutique

Info

Publication number
CA1008074A
CA1008074A CA209,631A CA209631A CA1008074A CA 1008074 A CA1008074 A CA 1008074A CA 209631 A CA209631 A CA 209631A CA 1008074 A CA1008074 A CA 1008074A
Authority
CA
Canada
Prior art keywords
pyrimidinic
arylamino
derivatives
preparation
therapeutical applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA209,631A
Other languages
English (en)
French (fr)
Other versions
CA209631S (en
Inventor
Claude Fauran
Guy Raynaud
Guy Bourgery
Claude Gouret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7333831A external-priority patent/FR2244459A1/fr
Priority claimed from FR7410327A external-priority patent/FR2265386A2/fr
Application filed by Delalande SA filed Critical Delalande SA
Application granted granted Critical
Publication of CA1008074A publication Critical patent/CA1008074A/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA209,631A 1973-09-20 1974-09-18 Derives arylamino pyrimidiniques, leur procede de preparation et leur application en therapeutique Expired CA1008074A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7333831A FR2244459A1 (en) 1973-09-20 1973-09-20 2-Arylamino-pyrimidines - useful as sedatives, antiinflammatory, anti-ulcer, vasodilating, anticholinergic and anti-broncho- constricting agents and diuretics
FR7410327A FR2265386A2 (en) 1974-03-26 1974-03-26 2-Arylamino-pyrimidines - useful as sedatives, antiinflammatory, anti-ulcer, vasodilating, anticholinergic and anti-broncho- constricting agents and diuretics

Publications (1)

Publication Number Publication Date
CA1008074A true CA1008074A (fr) 1977-04-05

Family

ID=26217948

Family Applications (1)

Application Number Title Priority Date Filing Date
CA209,631A Expired CA1008074A (fr) 1973-09-20 1974-09-18 Derives arylamino pyrimidiniques, leur procede de preparation et leur application en therapeutique

Country Status (12)

Country Link
US (1) US3978055A (fi)
JP (1) JPS5088079A (fi)
CA (1) CA1008074A (fi)
CH (1) CH593266A5 (fi)
DE (1) DE2444426A1 (fi)
ES (1) ES429869A1 (fi)
GB (1) GB1430729A (fi)
IT (1) IT1062796B (fi)
LU (1) LU70791A1 (fi)
NL (1) NL7412494A (fi)
SE (1) SE410600B (fi)
SU (1) SU645569A3 (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1534593A (en) * 1976-09-03 1978-12-06 Soc D Etudes Prod Chimique N-2,6-dichlorophenyl-2-aminopyrimidine and therapeutic compositions containing it
JPS57203072A (en) * 1981-06-05 1982-12-13 Sankyo Co Ltd 4-anilinopyrimidine derivative, its preparation, antidepressant comprising it as active ingredient
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
US5254555A (en) * 1989-10-30 1993-10-19 Beecham Group P.L.C. Amino pyrimidin-7-yl substituted benzopyrans for treatment of hypertension
US7481790B2 (en) * 2000-12-27 2009-01-27 Advanced Cardiovascular Systems, Inc. Vessel enlargement by arteriogenic factor delivery
DE10133665A1 (de) * 2001-07-11 2003-01-30 Boehringer Ingelheim Pharma Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
US20030055263A1 (en) * 2001-07-11 2003-03-20 Boehringer Ingelheim Pharma Kg Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production
US7320989B2 (en) * 2003-02-28 2008-01-22 Encysive Pharmaceuticals, Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
AU2004218456A1 (en) * 2003-02-28 2004-09-16 Encysive Pharmaceuticals Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists.
WO2005047268A2 (en) * 2003-11-10 2005-05-26 X-Ceptor Therapeutics, Inc. Substituted pyrimidine compositions and methods of use
CN102127056B (zh) * 2003-12-03 2013-08-21 Ym生物科学澳大利亚私人有限公司 微管蛋白抑制剂
KR102275676B1 (ko) * 2012-11-21 2021-07-12 피티씨 테라퓨틱스, 인크. 치환된 리버스 피리미딘 bmi-1 저해제
KR102232595B1 (ko) 2013-08-30 2021-03-26 피티씨 테라퓨틱스, 인크. 치환된 피리미딘 bmi-1 저해제
US10584115B2 (en) 2013-11-21 2020-03-10 Ptc Therapeutics, Inc. Substituted pyridine and pyrazine BMI-1 inhibitors
CN104262263B (zh) * 2014-08-29 2017-01-11 西安交通大学 一种N,6二苯基嘧啶-4-胺类Bcr-Abl抑制剂及其制备方法和应用
EP3836932A2 (en) 2018-08-17 2021-06-23 PTC Therapeutics, Inc. Method for treating pancreatic cancer
EA202192117A1 (ru) * 2019-02-28 2021-11-23 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способ лечения множественной миеломы
CN114096537A (zh) * 2019-03-27 2022-02-25 Ptc医疗公司 肉瘤治疗方法的有用组合

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321478A (en) * 1963-09-20 1967-05-23 American Cyanamid Co Aminoethoxyphenyl amine, ether, and sulfide derivatives of pyrimidine

Also Published As

Publication number Publication date
SU645569A3 (ru) 1979-01-30
GB1430729A (en) 1976-04-07
NL7412494A (nl) 1975-03-24
SE7411806L (fi) 1975-03-21
US3978055A (en) 1976-08-31
AU7344174A (en) 1976-03-25
IT1062796B (it) 1985-01-31
SE410600B (sv) 1979-10-22
JPS5088079A (fi) 1975-07-15
DE2444426A1 (de) 1975-03-27
LU70791A1 (fi) 1975-06-11
ES429869A1 (es) 1976-10-01
CH593266A5 (fi) 1977-11-30

Similar Documents

Publication Publication Date Title
CA1029303A (en) Method of contraception by the administration of stage-combination preparations
CA1008074A (fr) Derives arylamino pyrimidiniques, leur procede de preparation et leur application en therapeutique
CA969187A (en) Aminohalopyridyloxy acids and derivatives thereof, their preparation and method of use
CA991379A (en) Form of ammonium tetramolybdate and method of preparation
CA1027563A (en) Phenothiazine derivatives, compositions thereof and methods of preparation thereof
CA1029302A (en) Method of contraception by the administration of stage-combination preparations
CA1031774A (en) Water-soluble derivative of 6-deoxy-tetracyclines and process for the preparation thereof
AU464457B2 (en) 6-trichloroacetamido-penicillanic acid derivatives and their preparation
AU483869B2 (en) Novel arylamino pyrimidinic derivatives their process of preparation and their therapeutic application
AU483202B2 (en) Method of contraception bythe administration of stage-combination preparations
CA975976A (en) Thawer-cooker and method of using the same
CA1030537A (en) Derivatives of 5-oxy-6-aminomethylbenzofuran and method for preparing same
CA873345A (en) Derivatives of nebularin, method of preparation and compositions thereof
AU477580B2 (en) Thiolincosaminide derivatives and processes for their preparation
AU493201B2 (en) Method of contraception bythe administration of stage combination preparations
AU457374B2 (en) Thieno-diazepin derivatives and method of preparation thereof
AU475973B2 (en) Penam derivatives and preparation thereof
AU478030B2 (en) Derivatives of quinuclidine, a method for obtaining them and their applications
CA903942A (en) Polyxylylidenes and method of preparation
CA912746A (en) Solid polyperfluorostyrene and method of preparation
AU485763B2 (en) V-p-zr catalysts and method of preparation thereof
AU458654B2 (en) Pyrimidine derivatives and their methods of preparation
AU477684B2 (en) Novel phenoxyalkylamine derivatives and preparation thereof
AU7659674A (en) Henoxypropylamine derivatives and preparation thereof
CA1031326A (en) Desalanyltetaine derivatives and the method for their preparation